| 000 | 01009 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513184413.0 | ||
| 264 | 0 | _c19990708 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)77180-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWechsler, M | |
| 245 | 0 | 0 |
_aChurg-Strauss syndrome. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 1999 |
||
| 300 |
_a1970-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aChurg-Strauss Syndrome _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndoles |
| 650 | 0 | 4 | _aPhenylcarbamates |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aTosyl Compounds _xadverse effects |
| 700 | 1 | _aDrazen, J M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 353 _gno. 9168 _gp. 1970-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)77180-4 _zAvailable from publisher's website |
| 999 |
_c10330084 _d10330084 |
||